152 related articles for article (PubMed ID: 38674198)
1. Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study.
Burciu C; Sirli R; Bende R; Vuletici D; Miutescu B; Moga T; Bende F; Popescu A; Sporea I; Koppandi O; Miutescu E; Iovanescu D; Danila M
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674198
[No Abstract] [Full Text] [Related]
2. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients.
Ülger Y; Delik A
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):769-773. PubMed ID: 34974464
[TBL] [Abstract][Full Text] [Related]
3. [A case of hepatocellular carcinoma with paraneoplastic hypercholesterolemia, thrombocytosis and hypoglycemia].
Inomata E; Sohda T; Nakane H; Morihara D; Hirose O; Kitamura Y; Iwata K; Irie M; Takeyama Y; Watanabe H; Sakisaka S
Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1231-5. PubMed ID: 17675826
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Luo JC; Hwang SJ; Wu JC; Lai CR; Li CP; Chang FY; Chiang JH; Lui WY; Chu CW; Lee SD
Hepatogastroenterology; 2002; 49(47):1315-9. PubMed ID: 12239934
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma.
Qu Q; Wang S; Chen S; Zhou L; Rui JA
Am Surg; 2014 Feb; 80(2):191-6. PubMed ID: 24480222
[TBL] [Abstract][Full Text] [Related]
6. [The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma].
Huh UY; Kim JH; Kim BH; Nam KD; Jang JY; Kim NH; Lee SK; Joo KR; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Korean J Hepatol; 2005 Sep; 11(3):275-83. PubMed ID: 16177554
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and prognosis of paraneoplastic syndromes in hepatocellular carcinoma.
Chang PE; Ong WC; Lui HF; Tan CK
ISRN Oncol; 2013; 2013():684026. PubMed ID: 24396608
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic syndromes in primary liver cell carcinoma in Nigeria.
Teniola SO; Ogunleye IO
Trop Geogr Med; 1994; 46(1):20-2. PubMed ID: 8165731
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic syndromes in hepatocellular carcinoma: a review.
Ong Y; Huey CWT; Shelat VG
Expert Rev Gastroenterol Hepatol; 2022 May; 16(5):449-471. PubMed ID: 35649187
[TBL] [Abstract][Full Text] [Related]
10. The incidence and characteristics of some paraneoplastic syndromes of hepatocellular carcinoma in Nigerian patients.
Ndububa DA; Ojo OS; Adetiloye VA; Rotimi O; Durosinmi MA; Uchegbu LO
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1401-4. PubMed ID: 10654801
[TBL] [Abstract][Full Text] [Related]
11. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Hwang SJ; Luo JC; Li CP; Chu CW; Wu JC; Lai CR; Chiang JH; Chau GY; Lui WY; Lee CC; Chang FY; Lee SD
World J Gastroenterol; 2004 Sep; 10(17):2472-7. PubMed ID: 15300887
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan.
Luo JC; Hwang SJ; Wu JC; Li CP; Hsiao LT; Lai CR; Chiang JH; Lui WY; Chang FY; Lee SD
Cancer; 1999 Sep; 86(5):799-804. PubMed ID: 10463978
[TBL] [Abstract][Full Text] [Related]
13. Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases.
Chu CW; Hwang SJ; Luo JC; Tsay SH; Li CP; Chang FY; Lee SD; Lui WY; Chiang JH
J Gastroenterol Hepatol; 1999 Aug; 14(8):807-10. PubMed ID: 10482434
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma.
Hwang SJ; Lee SD; Wu JC; Chang CF; Lu CL; Tsay SH; Lo KJ
Zhonghua Yi Xue Za Zhi (Taipei); 1994 May; 53(5):262-9. PubMed ID: 7518732
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.
Moreira DM; Gershman B; Lohse CM; Boorjian SA; Cheville JC; Leibovich BC; Thompson RH
World J Urol; 2016 Oct; 34(10):1465-72. PubMed ID: 26914818
[TBL] [Abstract][Full Text] [Related]
16. [Paraneoplastic syndromes during primary cancer of the liver in black Africa. Apropos of 430 cases].
Sankalé M; Bao O; Sow AM; Meroueh F
Sem Hop; 1969 Jan; 45(5):279-89. PubMed ID: 4183687
[No Abstract] [Full Text] [Related]
17. [A case of hepatocellular carcinoma with hypercholesterolemia, erythrocytosis and hypoglycemia (author's transl)].
Kawasaki T; Taketa K; Ueda M; Watanabe A; Watanabe M; Shimamura J; Okazaki S; Mitani K; Nakata K; Endo H; Nagashima H; Ogawa K
Nihon Shokakibyo Gakkai Zasshi; 1979 Sep; 76(9):1871-7. PubMed ID: 229286
[No Abstract] [Full Text] [Related]
18. Clear cell hepatocellular carcinoma: sudden death from severe hypoglycemia.
Ross JS; Kurian S
Am J Gastroenterol; 1985 Mar; 80(3):188-94. PubMed ID: 2983534
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.
Lemekhova A; Hornuss D; Polychronidis G; Mayer P; Rupp C; Longerich T; Weiss KH; Büchler M; Mehrabi A; Hoffmann K
World J Surg Oncol; 2020 May; 18(1):93. PubMed ID: 32397993
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytosis as a Rare Paraneoplastic Syndrome Occurring in Hepatocellular Carcinoma: A Case Report.
Abbas H; Hanif S; Tariq H; Chilimuri S
Gastroenterology Res; 2019 Apr; 12(2):96-99. PubMed ID: 31019620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
